{"url_path":"/sec/acut/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1850767/0001493152-26-023742-index.html","accession_number":"0001493152-26-023742","cik":"0001850767","ticker":"ACUT","issuer_name":"Accustem Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850767/0001493152-26-023742-index.html","primary_entity_key":"0001850767","primary_entity_name":"Accustem Sciences Inc."},"word_count":247,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\n**31.1 Certification by Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act**\n\n \n\n**31.2 Certification by Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act**\n\n \n\n**32.1 Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**\n\n \n\n**32.2 Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**\n\n \n\n**101.INS*\nInline XBRL Instance Document**\n\n \n\n**101.SCH*\nInline XBRL Taxonomy Extension Schema Document**\n\n \n\n**101.CAL*\nInline XBRL Taxonomy Extension Calculation Linkbase Document**\n\n \n\n**101.DEF*\nInline XBRL Taxonomy Extension Definition Linkbase Document**\n\n \n\n**101.LAB*\nInline XBRL Taxonomy Extension Label Linkbase Document**\n\n \n\n**101.PRE*\nInline XBRL Taxonomy Extension Presentation Linkbase Document**\n\n \n\n**104\nCover Page Interactive Data File (embedded within the Inline XBRL document)**\n\n \n\n20\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed\non its behalf by the undersigned, thereunto duly authorized on May 15, 2026.\n\n \n\n \n**ACCUSTEM\nSCIENCES, INC.**\n\n \n \n\n \n*/s/\nKeeren Shah*\n\n \nKeeren Shah\n\n \nChief Financial Officer\n\n \n\nIn\naccordance with the Securities Exchange Act of 1934, this Report has been signed below on May 15, 2026 by the following persons on behalf\nof the Registrant and in the capacities indicated.\n\n \n\n*/s/\nWendy Blosser*\n \n\nWendy Blosser\n \n\nChief Executive Officer\nand Director\n \n\n \n \n\n*/s/\nKeeren Shah*\n \n\nKeeren Shah\n \n\nChief Financial Officer\n \n\n \n\n21"}